Appointment deepens scientific leadership as Decoy advances its Designable Multi-Antiviral pipeline toward clinical development NEW YORK and CAMBRIDGE, Mass., May 26, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a clinical-stage biotechnology company pioneering a new...
Hence then, the article about decoy therapeutics names brad pentelute mit professor of chemistry as chair of scientific advisory board was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board )
Also on site :
- Karol G Stunned by Surprise AMAs Win After Accepting International Artist of Excellence: ‘My Life Is Meaningful Because of My Music’
- Katseye Brings the AMAs’ House Down With Beary Exciting ‘Pinky Up’ Performance, Before Winning Best New Artist
- Girl Group KATSEYE Deliver Dance-Heavy “Pinky Up” Performance at 2026 AMAs